AllianceBernstein’s Mustang Bio MBIO Stock Holding History

AllianceBernstein’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-58	Closed	-$44K	–	3331
2022 Q1	$44K	Sell	58 -13	-18%	-$10.7K	﹤0.01%	3182
2021 Q4	$88K	Hold	71	–	–	﹤0.01%	3210
2021 Q3	$143K	Hold	71	–	–	﹤0.01%	3149
2021 Q2	$177K	Buy	71 +29	+69%	+$71.1K	﹤0.01%	3180
2021 Q1	$104K	Hold	42	–	–	﹤0.01%	3149
2020 Q4	$118K	Hold	42	–	–	﹤0.01%	3088
2020 Q3	$98K	Hold	42	–	–	﹤0.01%	3079
2020 Q2	$99K	Buy	+42	New	+$98.2K	﹤0.01%	3106

Other funds holding MBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

AllianceBernstein's MBIO Position: Q2 2022 in Review

AllianceBernstein sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 58 shares — an estimated $44K sold.

AllianceBernstein first reported a position in MBIO in Q2 2020 and held it in 8 quarters. The position peaked at $177K in Q2 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

AllianceBernstein reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
AllianceBernstein sold 58 Mustang Bio shares in Q2 2022, an estimated $44K.
AllianceBernstein first reported a position in Mustang Bio in Q2 2020 and held it in 8 quarters.
AllianceBernstein's Mustang Bio position peaked at $177K in Q2 2021.
71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.